Publication:
Effects of the preoperative administration of Dexketoprofen Trometamol on pain and swelling after implant surgery: a randomized, double-blind controlled trial

Simple item page
dc.contributor.authorSánchez-Pérez, Arturo
dc.contributor.authorMuñoz-Peñalver, Jesús
dc.contributor.authorMoya Villaescusa, María José
dc.contributor.authorSánchez-Matás, Carmen
dc.contributor.departmentDermatología, Estomatología, Radiología y Medicina Física
dc.date.accessioned2024-09-04T08:40:54Z
dc.date.available2024-09-04T08:40:54Z
dc.date.issued2018-04-01
dc.description© 2018 American Academy of Implant Dentistry. This document is the Published version of a Published Work that appeared in final form in Journal of Oral Implantology (JOI). To access the final edited and published work see https://doi.org/10.1563/aaid-joi-D-17-00185
dc.description.abstractThe fear of postoperative pain is often mentioned by patients as one of the factors that is most frequently associated with dental implants. To reduce this factor, a single oral dose of 25 mg dexketoprofen trometamol (DKT) or placebo was administered 15 minutes before implant surgery. One hundred patients who required single-implant treatments were randomly assigned to 1 of 2 blinded groups. The patients in the test group were given 25 mg DKT (DKT group), and those in the control group were given 500 mg vitamin C as a placebo (PLACEBO group). A subjective visual analogue scale of 100 mm in length was used to evaluate pain. Inflammation and complications were assessed using a 5-point Likert scale. An analysis of variance, t-tests, and a Mann-Whitney U test were performed. Among the 100 patients, 83 completed the study (there were 8 dropouts in the PLACEBO group and 9 in the DKT group). The patients who received DKT reported a lower pain intensity during the immediate postoperative period. The inflammatory response was weaker in the DKT group than the control group at 48 hours, but bleeding was greater. There were no other complications in either of the groups. In conclusion, the preemptive use of 25 mg soluble DKT administered orally 15 minutes before implant surgery can reduce the severity of immediate postoperative pain.es
dc.formatapplication/pdfes
dc.format.extent8es
dc.identifier.citationJoy Oral Implantology, 2018, Vol. 44 (2), pp. 122–129
dc.identifier.doihttps://doi.org/10.1563/aaid-joi-D-17-00185
dc.identifier.issnPrint: 0160-6972
dc.identifier.issnElectronic: 1548-1336
dc.identifier.urihttp://hdl.handle.net/10201/143580
dc.languageenges
dc.publisherAmerican Academy of Implant Dentistry
dc.relationSin financiación externa a la Universidad.es
dc.relation.publisherversionhttps://meridian.allenpress.com/joi/article/44/2/122/2606/Effects-of-the-Preoperative-Administration-of
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPreemptive analgesiaes
dc.subjectDental implantses
dc.subjectDexketoprofen trometamoles
dc.subjectPostoperative/drug therapyes
dc.subjectDental implants/adverse effectses
dc.titleEffects of the preoperative administration of Dexketoprofen Trometamol on pain and swelling after implant surgery: a randomized, double-blind controlled triales
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
aaid-joi-d-17-00185.pdf
Size:
213.96 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.26 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Artículos